Under Armour, Inc. today announced that Reza Taleghani will join the company as Executive Vice President (EVP) and Chief Financial Officer (CFO) in February 2026. He will succeed David Bergman, a ...
Experts analyze how Trump's drug pricing policies, including Most Favored Nation (MFN) and tariffs, reshape pharma markets and impact patient costs and access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback